NDC 67296-2238-04 - Lorazepam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 67296-2238
- Requested NDC
- 67296-2238-04
- Package NDCs from labels
- 67296-2238-2, 67296-2238-4, 67296-2238-04
- Manufacturer
- Redpharm Drug
- Effective date
- 2026-05-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lorazepam - Redpharm Drug | Redpharm Drug | 2026-05-22 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 67296-2238-2 | Lorazepam | 5 in 1 BOTTLE, PLASTIC | TABLET | 5 | 1 | |
| 67296-2238-4 | Lorazepam | 10 in 1 BOTTLE, PLASTIC | TABLET | 10 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lorazepam | LORAZEPAM | Hikma Pharmaceuticals USA Inc. | 4084fa74-9fd2-45ef-9d56-27bfa31d4e46 | 2024-04-10 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | Hikma Pharmaceuticals USA Inc. | e9b54e42-04cf-4c62-90e1-36f7b31a4e81 | 2024-04-09 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | Bryant Ranch Prepack | ba34ddd2-9a47-48bf-8e55-f05e9085e5a8 | 2024-04-03 | Boxed warning, Warnings, Adverse reactions | 197901 O26FZP769L |
| Lorazepam | LORAZEPAM | Bryant Ranch Prepack | 8e3d44fb-24b7-4552-9e95-de3bf871a88b | 2024-04-03 | Boxed warning, Warnings, Adverse reactions | 197902 O26FZP769L |
| Lorazepam | LORAZEPAM | International Medication Systems, Limited | 7dda070d-7809-46c4-8592-eb4e4c509707 | 2024-03-04 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | Aphena Pharma Solutions - Tennessee, LLC | 82f79757-69f0-4a37-93a6-55b66ae86ad7 | 2024-02-06 | Boxed warning, Warnings, Adverse reactions | 197902 O26FZP769L |
| LORAZEPAM | LORAZEPAM | A-S Medication Solutions | 8602cef8-167e-4a8c-b10f-fc3295a3abcc | 2024-01-21 | Boxed warning, Warnings, Adverse reactions | 197901 O26FZP769L |
| Lorazepam | LORAZEPAM | Aphena Pharma Solutions - Tennessee, LLC | 973eff80-b2cd-42ca-8e88-e0151e691e59 | 2024-01-19 | Boxed warning, Warnings, Adverse reactions | 197901 O26FZP769L |
| Lorazepam | LORAZEPAM | Clinical Solutions Wholesale, LLC | fdc11b95-2233-42b4-b5f3-9390b5e9e1b2 | 2024-01-09 | Boxed warning, Warnings, Adverse reactions | 197901 197900 197902 O26FZP769L |
| Lorazepam | LORAZEPAM | Aphena Pharma Solutions - Tennessee, LLC | 0ce02d7d-d855-c73f-e063-6294a90abe93 | 2023-12-19 | Boxed warning, Warnings, Adverse reactions | 197900 O26FZP769L |
| Lorazepam | LORAZEPAM | Leading Pharma, LLC | 5ca13415-4b77-4131-a9d2-6db26bc49167 | 2023-12-10 | Boxed warning, Warnings, Adverse reactions | 197901 197900 197902 O26FZP769L |
| Lorazepam | LORAZEPAM | Asclemed USA, Inc. | 91da80c8-3162-43f0-b53e-897070b26a54 | 2023-11-29 | Boxed warning, Warnings, Adverse reactions | 197900 O26FZP769L |
| LORAZEPAM | LORAZEPAM | Aphena Pharma Solutions - Tennessee, LLC | 247110f2-5468-4593-8d86-41f8c869e03d | 2023-10-17 | Boxed warning, Warnings, Adverse reactions | 197901 O26FZP769L |
| Lorazepam | LORAZEPAM | Chartwell RX, LLC | e075c78d-f0c6-4380-b769-bb8833d23ba5 | 2023-09-01 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| LORAZEPAM | LORAZEPAM | A-S Medication Solutions | 823b1d71-a510-4d34-8015-60b55af23d78 | 2023-08-24 | Boxed warning, Warnings, Adverse reactions | 197901 O26FZP769L |
| Lorazepam | LORAZEPAM | Amneal Pharmaceuticals LLC | bf265c2e-ab2f-42e5-96cf-3998eb5a644d | 2023-07-28 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | Teva Pharmaceuticals USA, Inc. | 1bf22e97-9425-484d-bac6-519c6bae6a37 | 2023-06-01 | Boxed warning, Warnings, Adverse reactions | ANDA072927 0093-3426 197901 197900 197902 3b900315-3445-4802-8ae1-33b059003b84 1bf22e97-9425-484d-bac6-519c6bae6a37 O26FZP769L |
| Lorazepam | LORAZEPAM | Proficient Rx LP | a407d3fe-ff0f-45b0-8a1e-c7a2a11c5569 | 2023-03-01 | Boxed warning, Warnings, Adverse reactions | 197900 O26FZP769L |
| Lorazepam | LORAZEPAM | Proficient Rx LP | 73bf2b31-5c7e-4b3a-9e97-8304931510b0 | 2022-06-01 | Boxed warning, Warnings, Adverse reactions | 197901 O26FZP769L |
| Lorazepam | LORAZEPAM | Proficient Rx LP | 5b78f7af-0ad8-4fa1-a8c0-9308fe8d9b3a | 2022-05-01 | Boxed warning, Warnings, Adverse reactions | 197900 O26FZP769L |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.